E Fund Management Co., Ltd. Horizon Therapeutics Public LTD CO Transaction History

E Fund Management Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $53,350 - $62,383	-539 Reduced 11.98%	3,962 $458,000
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $95,472 - $111,368	991 Added 28.23%	4,501 $463,000
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $89,719 - $94,886	-836 Reduced 19.24%	3,510 $383,000
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $178,497 - $325,581	-2,861 Reduced 39.7%	4,346 $495,000
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $122,612 - $176,198	2,081 Added 40.6%	7,207 $446,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $195,562 - $286,594	2,463 Added 92.49%	5,126 $409,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $230,136 - $292,424	2,663 New	2,663 $280,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.